Self-injection has quietly become one of the most significant shifts in modern healthcare delivery. From chronic disease management to fertility treatments and hormone therapies, millions of patients are now expected to administer injections at home rather than in clinical settings. The global self-injection devices market is expected to reach over $19 billion by 2030.
According to Pourang Bral, general dentist and CEO of Painless World, the clinical rationale behind this shift is sound. "Home administration reduces costs, increases access, and alleviates pressure on healthcare facilities," Bral says. "But operational success depends on what happens after the patient leaves the clinic."
